James Regan

5.1k total citations
26 papers, 618 citations indexed

About

James Regan is a scholar working on Infectious Diseases, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James Regan has authored 26 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James Regan's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). James Regan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). James Regan collaborates with scholars based in United States, Canada and China. James Regan's co-authors include David M. Barrett, Jonathan Z. Li, John H. Lynch, Kevin M. Tomera, Daniel K. Hellerstein, Charles F. McKiel, Michael L. Blute, Manish C. Choudhary, Jonathan Abraham and Adrian Coscia and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Scientific Reports.

In The Last Decade

James Regan

24 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Regan United States 14 237 153 142 107 67 26 618
Vani Vannappagari United States 14 418 1.8× 55 0.4× 228 1.6× 42 0.4× 190 2.8× 71 1.3k
Patrick Whelan United States 10 90 0.4× 28 0.2× 114 0.8× 45 0.4× 38 0.6× 26 382
B. D. Bhatia India 15 41 0.2× 35 0.2× 218 1.5× 81 0.8× 68 1.0× 52 629
René Écochard France 15 173 0.7× 25 0.2× 134 0.9× 62 0.6× 127 1.9× 36 694
R. Hitchcock United Kingdom 11 29 0.1× 109 0.7× 41 0.3× 146 1.4× 53 0.8× 16 439
Z. Appelman Israel 18 49 0.2× 49 0.3× 52 0.4× 354 3.3× 48 0.7× 56 1.0k
Caroline G. Tai United States 14 191 0.8× 14 0.1× 93 0.7× 141 1.3× 114 1.7× 23 817
Manish Singla United States 13 80 0.3× 71 0.5× 146 1.0× 250 2.3× 81 1.2× 45 504
José Medina‐Pestana Brazil 15 259 1.1× 12 0.1× 63 0.4× 243 2.3× 328 4.9× 124 998
Ditte Mølgaard‐Nielsen Denmark 15 91 0.4× 11 0.1× 69 0.5× 126 1.2× 443 6.6× 25 1.1k

Countries citing papers authored by James Regan

Since Specialization
Citations

This map shows the geographic impact of James Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Regan more than expected).

Fields of papers citing papers by James Regan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Regan. The network helps show where James Regan may publish in the future.

Co-authorship network of co-authors of James Regan

This figure shows the co-authorship network connecting the top 25 collaborators of James Regan. A scholar is included among the top collaborators of James Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Regan. James Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pampena, M. Betina, Elise G. Viox, Kevin Nguyen, et al.. (2025). Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound. Proceedings of the National Academy of Sciences. 122(33). e2501037122–e2501037122.
2.
Regan, James, Yuting Jiang, Kevin D. Hall, et al.. (2023). Viral and immunologic evaluation of smokers with severe COVID-19. Scientific Reports. 13(1). 17898–17898. 2 indexed citations
3.
Etemad, Behzad, Christy L. Lavine, Yijia Li, et al.. (2023). Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption. Science Translational Medicine. 15(695). eabq4490–eabq4490. 12 indexed citations
4.
Regan, James, James P. Flynn, Manish C. Choudhary, et al.. (2022). Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay. Open Forum Infectious Diseases. 9(3). ofac022–ofac022. 11 indexed citations
5.
Wang, Chuangqi, Yijia Li, Paulina Kapłonek, et al.. (2022). The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia. mBio. 13(4). e0157722–e0157722. 9 indexed citations
6.
Sun, Xiaoming, Ce Gao, Ke Zhao, et al.. (2022). Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses. Frontiers in Immunology. 13. 984553–984553. 7 indexed citations
7.
Kim, Myung‐Ho, Shadi Salloum, Jeffrey Wang, et al.. (2021). Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. The Journal of Infectious Diseases. 224(5). 777–782. 19 indexed citations
8.
Yonker, Lael M., Julie Boucau, James Regan, et al.. (2021). Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. The Journal of Infectious Diseases. 224(11). 1821–1829. 42 indexed citations
9.
Siedner, Mark J., Julie Boucau, Rebecca F. Gilbert, et al.. (2021). Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections. JCI Insight. 7(2). 26 indexed citations
10.
Clark, Sarah A., Lars E. Clark, Junhua Pan, et al.. (2021). SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell. 184(10). 2605–2617.e18. 107 indexed citations
11.
Siddiqi, Hasan K., Brittany Weber, Guohai Zhou, et al.. (2020). Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia. The American Journal of Medicine. 134(4). 542–546. 19 indexed citations
12.
Li, Yijia, James Regan, Jesse Fajnzylber, et al.. (2020). Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19. Hepatology Communications. 5(3). 434–445. 40 indexed citations
13.
Davis, Kimberly M., et al.. (2009). Disclosure of diagnosis and treatment among early stage prostate cancer survivors. Patient Education and Counseling. 79(2). 239–244. 18 indexed citations
14.
Kumra, Sanjiv, Harvey N. Kranzler, Ginny Gerbino-Rosen, et al.. (2008). Clozapine Versus “High-Dose” Olanzapine in Refractory Early-Onset Schizophrenia: An Open-Label Extension Study. Journal of Child and Adolescent Psychopharmacology. 18(4). 307–316. 46 indexed citations
15.
16.
Preuss, Harry G., et al.. (2001). Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). International Urology and Nephrology. 33(2). 217–225. 32 indexed citations
17.
Regan, James. (1999). Introduction: Sexual Dysfunction—What Every Practitioner Should Know. Advances in Renal Replacement Therapy. 6(4). 295–295.
18.
Badlani, Gopal, James Regan, John H. Lynch, et al.. (1999). A new temporary catheter (ContiCath) for the treatment of temporary, reversible, postoperative urinary retention. Urology. 53(6). 1104–1107. 9 indexed citations
19.
Blute, Michael L., Kevin M. Tomera, Daniel K. Hellerstein, et al.. (1993). Transurethral Microwave Thermotherapy for Management of Benign Prostatic Hyperplasia: Results of the United States Prostatron Cooperative Study. The Journal of Urology. 150(5 Part 2). 1591–1596. 98 indexed citations
20.
Matsumoto, Alan H., et al.. (1991). Spectrum of renal vascular malformation. Urology. 38(4). 297–300. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vani Vannappagari Breakdown of academic impact, for papers by Patrick Whelan Breakdown of academic impact, for papers by B. D. Bhatia Breakdown of academic impact, for papers by René Écochard Breakdown of academic impact, for papers by R. Hitchcock Breakdown of academic impact, for papers by Z. Appelman Breakdown of academic impact, for papers by Caroline G. Tai Breakdown of academic impact, for papers by Manish Singla Breakdown of academic impact, for papers by José Medina‐Pestana Breakdown of academic impact, for papers by Ditte Mølgaard‐Nielsen
Rankless by CCL
2026